Reuters logo
BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate
September 15, 2017 / 4:50 AM / 2 months ago

BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate

Sept 15 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd :

* Says its pharma unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration

* Certificate issued to API (azithromycin) manufactured by the unit and the valid period is until Aug. 29, 2022

Source text in Chinese: goo.gl/UUpuUq

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below